[go: up one dir, main page]

ZA200907355B - Titration of tapentadol - Google Patents

Titration of tapentadol

Info

Publication number
ZA200907355B
ZA200907355B ZA200907355A ZA200907355A ZA200907355B ZA 200907355 B ZA200907355 B ZA 200907355B ZA 200907355 A ZA200907355 A ZA 200907355A ZA 200907355 A ZA200907355 A ZA 200907355A ZA 200907355 B ZA200907355 B ZA 200907355B
Authority
ZA
South Africa
Prior art keywords
tapentadol
titration
administration
unitbcontaining
unitacontaining
Prior art date
Application number
ZA200907355A
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200907355(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of ZA200907355B publication Critical patent/ZA200907355B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200907355A 2007-04-23 2009-10-20 Titration of tapentadol ZA200907355B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol

Publications (1)

Publication Number Publication Date
ZA200907355B true ZA200907355B (en) 2010-08-25

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907355A ZA200907355B (en) 2007-04-23 2009-10-20 Titration of tapentadol

Country Status (21)

Country Link
US (4) US20090012180A1 (es)
EP (5) EP1985292A1 (es)
JP (4) JP5933176B2 (es)
KR (3) KR20150027840A (es)
CN (1) CN101730530B (es)
AT (1) ATE534378T1 (es)
AU (1) AU2008241013B2 (es)
CA (1) CA2683786C (es)
CY (1) CY1112320T1 (es)
DK (1) DK2148670T3 (es)
ES (1) ES2378255T3 (es)
HR (1) HRP20120147T1 (es)
IL (1) IL201479A (es)
MX (1) MX2009011444A (es)
NZ (1) NZ580415A (es)
PL (1) PL2148670T3 (es)
PT (1) PT2148670E (es)
RU (1) RU2472497C2 (es)
SI (1) SI2148670T1 (es)
WO (1) WO2008128740A1 (es)
ZA (1) ZA200907355B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
JP6216489B2 (ja) * 2008-10-30 2017-10-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 新規の、効力のあるタペンタドール剤形
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
WO2011138037A2 (de) * 2010-05-05 2011-11-10 Ratiopharm Gmbh Festes tapentadol in nicht-kristalliner form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2588093B1 (en) * 2010-06-30 2016-06-15 Grünenthal GmbH Tapentadol for use in the treatment of irritable bowel syndrome
MX341072B (es) * 2010-07-23 2016-08-05 Grünenthal Gmbh * Sales o co-cristales de 3-(3-dimetilamino-1-etil-2-metil-propil)-f enol.
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
KR102051800B1 (ko) 2011-03-04 2019-12-04 그뤼넨탈 게엠베하 경구 투여를 위한 타펜타돌의 수성 약제학적 제형
CA2828637C (en) 2011-03-04 2019-06-11 Grunenthal Gmbh Semisolid aqueous pharmaceutical composition containing tapentadol
KR101970468B1 (ko) * 2011-03-04 2019-04-19 그뤼넨탈 게엠베하 타펜타돌의 비경구 투여
PL2694049T3 (pl) 2011-04-05 2019-07-31 Grünenthal GmbH Tapentadol do zapobiegania przechodzeniu bólu w stan przewlekły
WO2012136351A1 (en) * 2011-04-05 2012-10-11 Grünenthal GmbH Tapentadol for treating pain associated with trigeminal neuralgia
PT2701693T (pt) 2011-04-29 2017-11-16 Gruenenthal Gmbh Tapentadol para prevenção e tratamento de depressão e ansiedade
ES2681952T3 (es) * 2013-03-15 2018-09-17 SpecGx LLC Forma farmacéutica sólida disuasoria del abuso de liberación inmediata con puntaje funcional
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
PT3273953T (pt) 2015-03-27 2019-04-01 Gruenenthal Gmbh Formulação estável para administração parentérica de tapentadol
US10471025B2 (en) * 2015-05-26 2019-11-12 Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa Compositions for use in treating parkinson's disease and related disorders
JP7373904B2 (ja) * 2016-02-29 2023-11-06 パーク・セラピューティクス・インコーポレイテッド セブラノパドールの滴定
BR112019005439A2 (pt) 2016-09-23 2019-06-18 Gruenenthal Gmbh formulação estável para administração parenteral de tapentadol
ES3010208T3 (en) 2020-03-16 2025-04-01 Gruenenthal Gmbh Scored tablet comprising tapentadol
AU2022236428A1 (en) * 2021-03-17 2023-11-02 Laboratoires Juvise Pharmaceuticals Pharmaceutical dosage system
US20240238221A1 (en) * 2021-05-07 2024-07-18 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
JP5054893B2 (ja) 2002-12-13 2012-10-24 ユーロ−セルティーク エス．エイ． 鎮痛のためのブプレノルフィン経皮投与計画
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol

Also Published As

Publication number Publication date
KR20100017267A (ko) 2010-02-16
IL201479A0 (en) 2010-05-31
EP2148670B1 (en) 2011-11-23
US20170079938A1 (en) 2017-03-23
JP5933176B2 (ja) 2016-06-08
KR102078999B1 (ko) 2020-02-19
CN101730530B (zh) 2013-10-23
EP2422778A1 (en) 2012-02-29
CA2683786A1 (en) 2008-10-30
MX2009011444A (es) 2009-11-05
JP2019131598A (ja) 2019-08-08
CN101730530A (zh) 2010-06-09
KR20180004839A (ko) 2018-01-12
EP3603630A1 (en) 2020-02-05
RU2472497C2 (ru) 2013-01-20
PT2148670E (pt) 2012-01-24
SI2148670T1 (sl) 2012-03-30
US20090012180A1 (en) 2009-01-08
JP2018030864A (ja) 2018-03-01
ATE534378T1 (de) 2011-12-15
WO2008128740A1 (en) 2008-10-30
ES2378255T3 (es) 2012-04-10
EP3143993A1 (en) 2017-03-22
KR20150027840A (ko) 2015-03-12
AU2008241013A1 (en) 2008-10-30
US20160074342A1 (en) 2016-03-17
CA2683786C (en) 2021-10-26
CY1112320T1 (el) 2015-12-09
US11344512B2 (en) 2022-05-31
EP1985292A1 (en) 2008-10-29
JP2010531296A (ja) 2010-09-24
DK2148670T3 (da) 2012-03-12
PL2148670T3 (pl) 2012-04-30
US20190290603A1 (en) 2019-09-26
WO2008128740A8 (en) 2010-06-17
RU2009142940A (ru) 2011-05-27
NZ580415A (en) 2012-04-27
AU2008241013B2 (en) 2013-06-20
HK1140940A1 (en) 2010-10-29
HRP20120147T1 (hr) 2012-03-31
JP2016128468A (ja) 2016-07-14
IL201479A (en) 2016-04-21
EP2148670A1 (en) 2010-02-03

Similar Documents

Publication Publication Date Title
ZA200907355B (en) Titration of tapentadol
MX2010009222A (es) Soluciones farmaceuticas, proceso de preparacion y usos terapeuticos.
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MY153408A (en) Novel methods
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
UA105210C2 (ru) Противораковая вакцина и ее применение
MX2011007930A (es) Conjugados de insulina cristalina.
MX356210B (es) Formulaciones de polimero acrilico.
IN2012DN01435A (es)
WO2008087186A3 (en) Peptides for use in the treatment of obesity
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
TN2012000515A1 (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
WO2011026125A3 (en) Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
IN2012DN01434A (es)
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
WO2008087188A3 (en) Peptides for use in the treatment of obesity
WO2012100043A3 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
MY150931A (en) Substituted oxazolidinones and their use
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
MX2009008108A (es) Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno.
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
TN2010000249A1 (en) New medical use of 3-(2,2,2-trimethylhydrazinium ) propionate salts
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата